Anthropic has launched Claude Frontier Academy, a $100 million training program to produce 10,000 Frontier Deployed Engineers by the end of...

Eli Lilly intends to innovate in the weight-loss market, launching up to four new products in the coming years. The success of Mounjaro and...

Eli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...

India’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...

Predictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Car...

While startups such as General Catalyst-backed Voy and Mumbai-based Metago are seeing higher demand from women, Elevate Now, backed by Tita...

Anthropic has released Claude Sonnet 5.5 on Monday. It is the second model in its Claude 5.5 family. The AI lab is expanding its product li...

Anthropic on Monday released Claude Sonnet 5.5, the second model in its Claude 5.5 family, as the AI lab expands its product lineup ahead o...

Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...

"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...

Drugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...

The condition is part of a list of areas, including addiction and menopause, where Novo sees potential overlap with either its core scienti...

Facing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...

At a time when fears of AI are gripping the public, the startup has built a wet lab, or place for physical experiments, in the San Francisc...

The Danish drugmaker will initially test Anthropic models and Claude Science in its research and development workflows, and address scienti...

India's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...

Eli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...